Risk of tumorigenicity in mesenchymal stromal cell-based therapies-Bridging scientific observations and regulatory viewpoints

Author(s):
Barkholt, L.; Flory, E.; Jekerle, V.; Lucas-Samuel, S.; Ahnert, P.; Bisset, L.; Buscher, D.; Fibbe, W.; Foussat, A.; Kwa, M.; Lantz, O.; Maciulaitis, R.; Palomaki, T.; Schneider, C.K.; Sensebe, L.; Tachdjian, G.; Tarte, K.; Tosca, L.; Salmikangas, P.
Published
2013
Publication type
Article / Letter to editor
cellmesenchymalstromaltumorigenicity
Date issued
2013-07-31
Language
English
Is part of
Cytotherapy (2013), Vol. 15, no. 7, p. 753-759
hdl
1887/102431
doi
10.1016/j.jcyt.2013.03.005